{
  "id": 197,
  "text": "Three dimensional and 2D dose volume and point constraints for rectum, bladder, vagina, sigmoid, and bowel are recommended, and they have to be based on the published clinical evidence10-12.Point A dose normalization should be used as starting point for stepwise treatment plan optimization, although point A dose reporting and prescription have been extended by the volumetric approach10-12.",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Three dimensional and 2D dose volume and point constraints for rectum, bladder, vagina, sigmoid, and bowel are recommended, and they have to be based on the published clinical evidence10-12.Point A dose normalization should be used as starting point for stepwise treatment plan optimization, although point A dose reporting and prescription have been extended by the volumetric approach10-12.\n\n<question>: ",
  "ChatGPT_response_0": "在放疗治疗计划中，应该根据直肠、膀胱、阴道、乙状结肠和肠道等器官的临床证据进行剂量限制。这些限制可以根据已发表的临床证据进行制定，其中点A剂量归一化可作为逐步治疗计划优化的起点。此外，通过体积方法扩展了点A剂量的报告和处方。",
  "query": "在放疗治疗计划中，您认为应该根据哪些器官的临床证据进行剂量限制？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: 在放疗治疗计划中，您认为应该根据哪些器官的临床证据进行剂量限制？\n\n<reference text>: Three dimensional and 2D dose volume and point constraints for rectum, bladder, vagina, sigmoid, and bowel are recommended, and they have to be based on the published clinical evidence10-12.Point A dose normalization should be used as starting point for stepwise treatment plan optimization, although point A dose reporting and prescription have been extended by the volumetric approach10-12.\n\n<reply>: ",
  "response": "在放疗治疗计划中，应该根据直肠、膀胱、阴道、乙状结肠和肠道等器官的临床证据进行剂量限制。这些限制可以根据已发表的临床证据进行制定，其中点A剂量归一化可作为逐步治疗计划优化的起点。此外，通过体积方法扩展了点A剂量的报告和处方。"
}